These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata. Fallatah W, Smith T, Cui W, Jayasinghe D, Di Pietro E, Ritchie SA, Braverman N. Dis Model Mech; 2020 Jan 24; 13(1):. PubMed ID: 31862688 [Abstract] [Full Text] [Related]
16. Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice. Brites P, Ferreira AS, da Silva TF, Sousa VF, Malheiro AR, Duran M, Waterham HR, Baes M, Wanders RJ. PLoS One; 2011 Jul 24; 6(12):e28539. PubMed ID: 22163031 [Abstract] [Full Text] [Related]
17. Expanding the genotypic and phenotypic landscapes of rhizomelic chondrodysplasia punctata type 3 (RCDP3) with two novel families, and a review of the literature. İli EG, Gezdirici A, Di Pietro E, Yergeau C, Braverman N. Am J Med Genet A; 2022 Nov 24; 188(11):3229-3235. PubMed ID: 35986576 [Abstract] [Full Text] [Related]
18. Defective lipid remodeling of GPI anchors in peroxisomal disorders, Zellweger syndrome, and rhizomelic chondrodysplasia punctata. Kanzawa N, Shimozawa N, Wanders RJ, Ikeda K, Murakami Y, Waterham HR, Mukai S, Fujita M, Maeda Y, Taguchi R, Fujiki Y, Kinoshita T. J Lipid Res; 2012 Apr 24; 53(4):653-63. PubMed ID: 22253471 [Abstract] [Full Text] [Related]